c-Cbl is tyrosine-phosphorylated by interleukin-4 and enhances mitogenic and survival signals of interleukin-4 receptor by linking with the phosphatidylinositol 3'-kinase pathway

Blood

Volumn 91, Issue 1, 1998, Pages 46-53

  Ueno, Hiroo ^a   Sasaki, Ko ^a   Honda, Hiroaki ^a   Nakamoto, Tetsuya ^a   Yamagata, Tetsuya ^a   Miyagawa, Kiyoshi ^a   Mitani, Kinuko ^a   Yazaki, Yoshio ^a   Hirai, Hisamaru ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; TYROSINE; WORTMANNIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; B LYMPHOCYTE; BINDING SITE; CELL SURVIVAL; ENZYME ACTIVATION; GENE OVEREXPRESSION; MITOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTO ONCOGENE;

EID: 0031964845     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.1.46.46_46_53     Document Type: Article

References (49)

1. Keegan A, Nelms K, Wang L, Pierce J, Paul W: IL-4 receptor: Signaling mechanisms. Immunol Today 15:423, 1994
2. Widmer MB, Acres RB, Sassenfeld HM, Grabstein KH: Cloning and expression of the human interleukin-6 (BSF-2/IFN beta 2) receptor. J Exp Med 166:1447, 1987
3. Murata T, Noguchi PD, Puri RK: Receptors for interleukin (IL)-4 do not associate with the common gamma chain, and IL-4 induces the phosphorylation of JAK2 tyrosine kinase in human colon carcinoma cells. J Biol Chem 270:30829, 1995
4. Mosley B, Beckmann MP, March CJ, Idzerda RL, Gimpel SD, VandenBos T, Friend D, Alpert A, Anderson D, Jackson J, Wignall JM, Smith C, Gallis B, Sims JE, Urdal D, Widmer MB, Cosman D, Park LS: The marine interleukin-4 receptor: Molecular cloning and characterization of secreted and membrane bound forms. Cell 59:335, 1989
5. Harada N, Castle BE, Gorman DM, Itoh N, Schreurs J, Barrett RL, Howard M, Miyajima A: Expression cloning of a cDNA encoding the murine interleukin 4 receptor based on ligand binding. Proc Natl Acad Sci USA 87:857, 1990
6. Takeshita T, Asao H, Ohtani K, Ishii N, Kumaki S, Tanaka N, Munakata H, Nakamura M, Sugamura K: Cloning of the gamma chain of the human IL-2 receptor. Science 257:379, 1992
7. Noguchi M, Nakamura Y, Russell SM, Ziegler SF, Tsang M, Cao X, Leonard WJ: Interleukin-2 receptor gamma chain: A functional component of the interleukin-7 receptor. Science 262:1877, 1993
8. Giri JG, Ahdieh M, Eisenman J, Shanebeck K, Grabstein K, Kumaki S, Namen A, Park LS, Cosman D, Anderson D: Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J 13:2822, 1994
9. Kondo M, Takeshita T, Higuchi M, Nakamura M, Sudo T, Nishikawa S, Sugamura K: Functional participation of the IL-2 receptor gamma chain in IL-7 receptor complexes. Science 263:1453, 1994
10. Puck JM, Deschenes SM, Porter JC, Dutra AS, Brown CJ, Willard HF, Henthorn PS: The interleukin-2 receptor gamma chain maps to Xq13.1 and is mutated in X-linked severe combined immunodeficiency, SCIDX1. Hum Mol Genet 2:1099, 1993
11. Yin T, Tsang ML, Yang YC: JAK1 kinase forms complexes with interleukin-4 receptor and 4PS/insulin receptor substrate-1-like protein and is activated by interleukin-4 and interleukin-9 in T lymphocytes. J Biol Chem 269:26614, 1994
12. Brunn GJ, Falls EL, Nilson AE, Abraham RT: Protein-tyrosine kinase-dependent activation of STAT transcription factors interleukin-2-or interleukin-4-stimulated T lymphocytes. J Biol Chem 270: 11628, 1995
13. Lai S, Molden J, Liu K, Puck J, White M, Goldsmith M: Interleukin-4-specific signal transduction events are driven by homotypic interactions of the interleukin-4 receptor a subunit. EMBO J 15:4506, 1996
14. Takeda K, Tanaka T, Shi W, Matsumoto M, Minami M, Kashiwamura S, Nakanishi K, Yoshida N, Kishimoto T, Akira S: Essential role of Stat6 in IL-4 signalling. Nature 380:627, 1996
15. Wang LM, Keegan AD, Li W, Lienhard GE, Pacini S, Gutkind JS, Myers MJ, Sun XJ, White MF, Aaronson SA, Paul WE, Pierce JH: Common elements in interleukin 4 and insulin signaling pathways in factor-dependent hematopoietic cells. Proc Natl Acad Sci USA 90:4032, 1993
16. Seldin DC, Leder P: Mutational analysis of a critical signaling domain of the human interleukin 4 receptor. Proc Natl Acad Sci USA 91:2140, 1994
17. Sun XJ, Wang L-M, Zhang Y, Yenush L, Myers Jr MG, Glasheen E, Lane WS, Pierce JH, White MF: Role of IRS-2 in insulin and cytokine signaling. Nature 377:173, 1995
18. Langdon WY, Hyland CD, Grumont RJ, Morse Hd: The c-cbl proto-oncogene is preferentially expressed in thymus and testis tissue and encodes a nuclear protein. J Virol 63:5420, 1989
19. Blake TJ, Shapiro M, Morse Hd, Langdon WY: The sequences of the human and mouse c-cbl proto-oncogenes show v-cbl was generated by a large truncation encompassing a proline-rich domain and a leucine zipper-like motif. Oncogene 6:653, 1991
20. Donovan JA, Wange RL, Langdon WY, Samelson LE: The protein product of the c-cbl protooncogene is the 120-kDa tyrosine-phosphorylated protein in Jurkat cells activated via the T cell antigen receptor. J Biol Chem 269:22921, 1994
21. Rivero LO, Sameshima JH, Marcilla A, Robbins KC: Physical association between Src homology 3 elements and the protein product of the c-cbl proto-oncogene. J Biol Chem 269:17363, 1994
22. de Jong R, ten Hoeve J, Heisterkamp N, Groffen J: Crkl is cornplexed with tyrosine-phosphorylated Cbl in Ph-positive leukemia. J Biol Chem 270:21468, 1995
23. Meisner H, Conway BR, Hartley D, Czech MP: Interactions of Cbl with Grb2 and phosphatidylinositol 3′-kinase in activated Jurkat cells. Mol Cell Biol 15:3571, 1995
24. Odai H, Sasaki K, Iwamatsu A, Hanazono Y, Tanaka T, Mitani K, Yazaki Y, Hirai H: The proto-oncogene product c-Cbl becomes tyrosine phosphorylated by stimulation with GM-CSF or Epo and constitutively binds to the SH3 domain of Grb2/Ash in human hematopoietic cells. J Biol Chem 270:10800, 1995
25. Odai H, Sasaki K, Hanazono Y, Ueno H, Tanaka T, Miyagawa K, Mitani K, Yazaki Y, Hirai H: c-Cbl is inducibly tyrosine-phosphorylated by epidermal growth factor stimulation in fibroblasts, and constitutively tyrosine-phosphorylated and associated with v-src in v-src-transformed fibroblasts. Jpn J Cancer Res 86:1119, 1995
26. Ribon V, Hubbell S, Herrera R, Saltiel AR: The product of the cbl oncogene forms stable complexes in vivo with endogenous Crk in a tyrosine phosphorylation-dependent manner. Mol Cell Biol 16:45, 1996
27. Sasaki K, Odai H, Hanazono Y, Ueno H, Ogawa S, Langdon WY, Tanaka T, Miyagawa K, Mitani K, Yazaki Y, Hirai H: TPO/c-mpl ligand induces tyrosine phosphorylation of multiple cellular proteins including proto-oncogene products, Vav and c-Cbl, and Ras signaling molecules. Biochem Biophys Res Commun 216:338, 1995
28. Tanaka S, Neff L, Baron R, Levy JB: Tyrosine phosphorylation and translocation of the c-cbl protein after activation of tyrosine kinase signaling pathways. J Biol Chem 270:14347, 1995
29. Galisteo ML, Dikic I, Batzer AG, Langdon WY, Schlessinger J: Tyrosine phosphorylation of the c-cbl proto-oncogene protein product and association with epidermal growth factor (EGF) receptor upon EGF stimulation. J Biol Chem 270:20242, 1995
30. Levkowitz G, Klapper LN, Tzahar E, Freywald A, Sela M, Yarden Y: Coupling of the c-Cbl protooncogene product to ErbB-1/EGF-receptor but not to other ErbB proteins. Oncogene 12:1117, 1996
31. Jongeward GD, Clandinin TR, Sternberg PW: sli-1, a negative regulator of let-23-mediated signaling in C. elegans. Genetics 139: 1553, 1995
32. Yoon CH, Lee J, Jongeward GD, Sternberg PW: Similarity of sli-1, a regulator of vulval development in C. elegans, to the mammalian proto-oncogene c-cbl. Science 269:1102-5, 1995
33. Welham MJ, Duronio V, Schrader JW: Interleukin-4-dependent proliferation dissociates p44erk-1, p42erk-2, and p21ras activation from cell growth. J Biol Chem 269:5865, 1994
34. Ueno H, Sasaki K, Miyagawa K, Honda H, Mitani K, Yazaki Y, Hirai H: Antisense repression of proto-oncogene c-Cbl enhances activation of the JAK-STAT pathway but not the Ras pathway in EGF receptor signaling. J Biol Chem 272:8739, 1997
35. Ueno H, Sasaki K, Kozutsumi H, Miyagawa K, Mitani K, Yazaki Y, Hirai H: Growth and survival signals transmitted via two distinct NPXY motifs within leukocyte tyrosine kinase, an insulin receptor-related tyrosine kinase. J Biol Chem 271:27707, 1996
36. Ueno H, Hirano N, Kozutsumi H, Sasaki K, Tanaka T, Yazaki Y, Hirai H: An epidermal growth factor receptor-leukocyte tyrosine kinase chimeric receptor generates ligand-dependent growth signals through the Ras signaling pathway. J Biol Chem 270:20135, 1995
37. Yamauchi T, Tobe K, Tamemoto H, Ueki K, Kaburagi Y, Yamamoto HR, Takahashi Y, Yoshizawa F, Aizawa S, Akanuma Y, Sonenberg N, Yazaki Y, Kadowaki T: Insulin signalling and insulin actions in the muscles and livers of insulin-resistant, insulin receptor substrate 1-deficient mice. Mol Cell Biol 16:3074, 1996
38. Kelso A, Troutt AB: Survival of the myeloid progenitor cell line FDC-P1 is prolonged by interferon-gamma or interleukin-4. Growth Factors 6:233, 1992
39. Keegan AD, Nelms K, White M, Wang LM, Pierce JH, Paul WE: An IL-4 receptor region containing an insulin receptor motif is important for IL-4-mediated IRS-1 phosphorylation and cell growth. Cell 76:811, 1994
40. Parry SL, Hasbold J, Holman M, Klaus GG: Hypercross-linking surface IgM or IgD receptors on mature B cells induces apoptosis that is reversed by costimulation with IL-4 and anti-CD40. J Immunol 152:2821, 1994
41. Songyang Z, Shoelson SE, Chaudhuri M, Gish G, Pawson T, Haser WG, King F, Roberts T, Ratnofsky S, Lechleider RJ, Neel BG, Birge RB, Fajardo JE, Chou MM, Hanafusa H, Schaffhausen B, Cantley LC: SH2 domains recognize specific phosphopeptide sequences. Cell 72:767, 1993
42. Songyang Z, Shoelson SE, McGlade J, Olivier P, Pawson T, Bustelo XR, Barbacid M, Sabe H, Hanafusa H, Yi T, Ren R, Baltimore D, Rantnofsky S, Feldman RA, Cantley LC: Specific motifs recognized by the SH2 domains of Csk, 3BP2, fps/fes, GRB-2, HCP, SHC, Syk, and Vav. Mol Cell Biol 14:2777, 1994
43. Sattler M, Salgia R, Okuda K, Uemura N, Durstin MA, Pisick E, Xu G, Li JL, Prasad KV, Griffin JD: The proto-oncogene product p120CBL and the adaptor proteins CRKL and c-CRK link c-ABL, p190BCR/ABL and p210BCR/ABL to the phosphatidylinositol-3′ kinase pathway. Oncogene 12:839, 1996
44. Yao R, Cooper GM: Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. Science 267:2003, 1995
45. Franke TF, Yang SI, Chan TO, Datta K, Kazlauskas A, Morrison DK, Kaplan DR, Tsichlis PN: The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell 81:727, 1995
46. Burgering BM, Coffer PJ: Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature 376:599, 1995
47. Dudek H, Datta SR, Franke TF, Birnbaum MJ, Yao R, Cooper GM, Segal RA, Kaplan DR, Greenberg ME: Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science 275:661, 1997
48. 48: Deutsch HH, Koettnitz K, Chung J, Kalthoff FS: Distinct sequence motifs within the cytoplasmic domain of the human IL-4 receptor differentially regulate apoptosis inhibition and cell growth. J Immunol 154:3696, 1995
49. Bellacosa A, Testa JR, Staal SP, Tsichlis PN: A retroviral oncogene, akt, encoding a serine-threonine kinase containing an SH2-like region. Science 254:274, 1991